RecruitingNCT05644548

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Retinal Vascular Manifestations in Patients With Common Internal Diseases on Optical Coherence Tomography Angiography


Sponsor

Beijing Tongren Hospital

Enrollment

300 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified. This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up. This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a non-invasive eye scan called OCTA (optical coherence tomography angiography) to look at the tiny blood vessels in the back of the eye in people with hypertension, diabetes, or high cholesterol, to see if eye vessel changes can reveal early cardiovascular damage. **You may be eligible if...** - You have been diagnosed with high blood pressure (hypertension), OR - You have been diagnosed with diabetes, OR - You have been diagnosed with high cholesterol (dyslipidemia) - You agree to participate in the study **You may NOT be eligible if...** - You have cancer - You have an autoimmune disease - You have an immune deficiency disease - You decline to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention


Locations(1)

Beijing Tongren Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05644548


Related Trials